The partners will collaborate to build a cutting-edge oligonucleotide cGMP manufacturing facility
Wacker Biotech is a CDMO for the GMP-compliant production of active ingredients for the pharmaceutical industry
The observations are procedural in nature and will be responded to within the stipulated time
The company had earlier announced about the approval received from the MHRA for Liraglutide
First and only long-acting C5 complement inhibitor offers patients with AQP4 Ab+
The inspection at Unit 1 by the USFDA has been successfully completed, with no observations under Form 483
Subscribe To Our Newsletter & Stay Updated